Hemorrhagic cystitis refers to the acute or chronic damage to the bladder caused by certain drugs or chemical agents in urine, leading to widespread inflammatory hemorrhage in the bladder. It is mainly divided into sudden hematuria and refractory hematuria, both of which can cause massive hemorrhage and induce anemia symptoms, requiring timely treatment.
This disease is a multi-causal complication, mainly caused by acute or chronic damage to the bladder mucosa due to the toxic and side effects of antitumor drugs, radiation rays, and viral infections, resulting in hemorrhage. Clinical data show that the amount and severity of bleeding are not directly related to the progression of the disease, but are closely related to the route, method of administration, and the duration of action of antitumor drugs, as well as the blood drug concentration. It often occurs during the treatment of bladder cancer, prostate cancer, rectal cancer, and cervical cancer. It also occurs in some viral infections, such as adenovirus and influenza virus infections.
Since the use of hydration, diuresis, especially sodium thioglycolate, and other preventive measures, this potentially life-threatening complication has been effectively controlled, but there are still severe cases of hemorrhagic cystitis occurring, with an incidence rate of 7%-52%, which deserves clinical attention.